These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27057541)

  • 1. Mathematical Model for an Effective Management of HIV Infection.
    Ogunlaran OM; Oukouomi Noutchie SC
    Biomed Res Int; 2016; 2016():4217548. PubMed ID: 27057541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and Long-Term Optimal Control of a Mathematical Model for HIV Infection of CD4+T Cells.
    Croicu AM
    Bull Math Biol; 2015 Nov; 77(11):2035-71. PubMed ID: 26493544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stochastic model for early HIV-1 population dynamics.
    Tuckwell HC; Le Corfec E
    J Theor Biol; 1998 Dec; 195(4):451-63. PubMed ID: 9837702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal HIV treatment by maximising immune response.
    Culshaw RV; Ruan S; Spiteri RJ
    J Math Biol; 2004 May; 48(5):545-62. PubMed ID: 15133623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy.
    Gumel AB; Loewen TD; Shivakumar PN; Sahai BM; Yu P; Garba ML
    Comput Biol Med; 2001 Sep; 31(5):287-301. PubMed ID: 11535198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
    Haase AT
    Annu Rev Immunol; 1999; 17():625-56. PubMed ID: 10358770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal treatment strategies to control acute HIV infection.
    Ahmed S; Rahman S; Kamrujjaman M
    Infect Dis Model; 2021; 6():1202-1219. PubMed ID: 34786525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management.
    Phillips AN; McLean A; Johnson MA; Tyrer M; Emery V; Griffiths P; Bofill M; Janossy G; Loveday C
    J Med Virol; 1997 Nov; 53(3):261-5. PubMed ID: 9365893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical Analysis of the Effects of HIV-Malaria Co-infection on Workplace Productivity.
    Seidu B; Makinde OD; Seini IY
    Acta Biotheor; 2015 Jun; 63(2):151-82. PubMed ID: 25980477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal control of HIV dynamic using embedding method.
    Zarei H; Kamyad AV; Farahi MH
    Comput Math Methods Med; 2011; 2011():674318. PubMed ID: 21687584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal control therapy and vaccination for special HIV-1 model with delay.
    Shamsara E; Shamsara J; Afsharnezhad Z
    Theory Biosci; 2016 Dec; 135(4):217-230. PubMed ID: 27488866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 infection dynamics and optimal control with Crowley-Martin function response.
    Naeem Jan M; Ali N; Zaman G; Ahmad I; Shah Z; Kumam P
    Comput Methods Programs Biomed; 2020 Sep; 193():105503. PubMed ID: 32387782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling Optimal Control of In-Host HIV Dynamics Using Different Control Strategies.
    Ngina P; Mbogo RW; Luboobi LS
    Comput Math Methods Med; 2018; 2018():9385080. PubMed ID: 29971134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug Therapy for HIV Infection: Dynamics of Immune System.
    Kamboj D; Sharma MD
    Acta Biotheor; 2019 Jun; 67(2):129-147. PubMed ID: 30515609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
    Forde J; Volpe JM; Ciupe SM
    Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-1 quantitative dynamics in vivo: a review of mathematical models].
    Le Corfec E; Rouzioux C; Costagliola D
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):168-81. PubMed ID: 10804426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2005 Jul; 67(4):783-813. PubMed ID: 15893553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
    Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
    J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.